# EXPAREL or Lidocane as Local Anesthetic in Patients Undergoing Pleuroscopy With Pleural Biopsy and Indwelling Pleural Catheter Placement

> **NCT05044468** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 80 (estimated)

## Conditions studied

- Malignant Pleural Neoplasm

## Interventions

- **DRUG:** Lidocaine
- **DRUG:** Liposomal Bupivacaine
- **OTHER:** Questionnaire Administration

## Key facts

- **NCT ID:** NCT05044468
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-03-23
- **Primary completion:** 2026-05-31
- **Final completion:** 2026-05-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05044468

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05044468, "EXPAREL or Lidocane as Local Anesthetic in Patients Undergoing Pleuroscopy With Pleural Biopsy and Indwelling Pleural Catheter Placement". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05044468. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*